Home » Topics » BioWorld Science

BioWorld Science
RSS

Russian investigators patent ciprofloxacin derivatives

May 30, 2018

Auckland Uniservices divulges CSF1R inhibitors

May 30, 2018

U.S. researchers patent ITGA4 antagonists

May 30, 2018

FDA accepts NDA for larotrectinib and grants priority review

May 30, 2018

FDA accepts NDA and grants priority review status for Firdapse

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

ITGA3 suggested as a therapeutic target in bladder cancer

May 30, 2018

Pivotal phase III of chidamide in combination with exemestane reaches primary endpoint

May 30, 2018

Clinical trial authorization received in U.K. to initiate phase I study with OLX-10010

May 30, 2018

Xalkori receives FDA breakthrough therapy designation in two new indications

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...